A vaginal compound containing 300 mg of LF was administered randomly 4 or 12 h prior to amniocentesis , as to obtain 3 groups : A , 20 untreated patients ; B , 20 treated 4 h before amniocentesis ; C , 20 treated 12 h before amniocentesis .